Roufosse C - Search Results

1

Genes expressed by both mesangial cells and bone marrow-derived cells underlie genetic susceptibility to crescentic glomerulonephritis in the rat.

Smith J, Lai PC, Behmoaras J, Roufosse C, Bhangal G, McDaid JP, Aitman T, Tam FW, Pusey CD, Cook HT. Smith J, et al. Among authors: roufosse c. J Am Soc Nephrol. 2007 Jun;18(6):1816-23. doi: 10.1681/ASN.2006070733. Epub 2007 May 2. J Am Soc Nephrol. 2007. PMID: 17475818

2

Circulating mesenchymal stem cells.

Roufosse CA, Direkze NC, Otto WR, Wright NA. Roufosse CA, et al. Int J Biochem Cell Biol. 2004 Apr;36(4):585-97. doi: 10.1016/j.biocel.2003.10.007. Int J Biochem Cell Biol. 2004. PMID: 15010325 Review.

3

DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy.

Lord GM, Hollstein M, Arlt VM, Roufosse C, Pusey CD, Cook T, Schmeiser HH. Lord GM, et al. Among authors: roufosse c. Am J Kidney Dis. 2004 Apr;43(4):e11-7. doi: 10.1053/j.ajkd.2003.11.024. Am J Kidney Dis. 2004. PMID: 15042566

4

Bone marrow-derived cells do not contribute significantly to collagen I synthesis in a murine model of renal fibrosis.

Roufosse C, Bou-Gharios G, Prodromidi E, Alexakis C, Jeffery R, Khan S, Otto WR, Alter J, Poulsom R, Cook HT. Roufosse C, et al. J Am Soc Nephrol. 2006 Mar;17(3):775-82. doi: 10.1681/ASN.2005080795. Epub 2006 Feb 8. J Am Soc Nephrol. 2006. PMID: 16467445

5

Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.

Prodromidi EI, Poulsom R, Jeffery R, Roufosse CA, Pollard PJ, Pusey CD, Cook HT. Prodromidi EI, et al. Stem Cells. 2006 Nov;24(11):2448-55. doi: 10.1634/stemcells.2006-0201. Epub 2006 Jul 27. Stem Cells. 2006. PMID: 16873763

6

Stem cells and renal regeneration.

Roufosse C, Cook HT. Roufosse C, et al. Nephron Exp Nephrol. 2008;109(2):e39-45. doi: 10.1159/000139989. Epub 2008 Jun 18. Nephron Exp Nephrol. 2008. PMID: 18560247 Free article. Review.

7

Pathological predictors of prognosis in immunoglobulin A nephropathy: a review.

Roufosse CA, Cook HT. Roufosse CA, et al. Curr Opin Nephrol Hypertens. 2009 May;18(3):212-9. doi: 10.1097/MNH.0b013e328329605c. Curr Opin Nephrol Hypertens. 2009. PMID: 19300248 Review.

8

Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy.

Willicombe M, Brookes P, Santos-Nunez E, Galliford J, Ballow A, Mclean A, Roufosse C, Cook HT, Dorling A, Warrens AN, Cairns T, Taube D. Willicombe M, et al. Among authors: roufosse c. Am J Transplant. 2011 Mar;11(3):470-7. doi: 10.1111/j.1600-6143.2010.03421.x. Epub 2011 Feb 7. Am J Transplant. 2011. PMID: 21299828 Free article.

9

Paraprotein 'zippers'.

Bravou V, McLean AG, Loucaidou M, Cairns TD, Cook HT, Roufosse CA. Bravou V, et al. Kidney Int. 2011 Jul;80(1):126. doi: 10.1038/ki.2011.54. Kidney Int. 2011. PMID: 21673739 Free article. No abstract available.

10

A case of chronic antibody-mediated rejection in the making.

Bravou V, Galliford J, McLean A, Willicombe M, Taube D, Cook HT, Roufosse C. Bravou V, et al. Among authors: roufosse c. Clin Nephrol. 2013 Oct;80(4):306-9. doi: 10.5414/CN107462. Clin Nephrol. 2013. PMID: 22579273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters